The Mexican Health authorities have approved bilastine, under
PFIZER's name, the leading pharmaceutical company in the
world and in Mexico.
The next step will be bilastine's commercialization by
Pfizer, with
FAES FARMA as the manufacturer.
Mexico is Latin America's second biggest pharmaceutical
market. On the other hand, FAES FARMA has obtained the
approval of its
venotonic hidrosmine in Venezuela, South America's third
biggest market. This is the first of the product line that
FAES FARMA will market under its own brand in that
country.
Both news are very positive and represent a major advance in
the progress of FAES FARMA's project in Latin America.
2nd July 2012
1
distributed by |